诚意药业
(603811)
| 流通市值：38.52亿 | | | 总市值：38.52亿 |
| 流通股本：3.27亿 | | | 总股本：3.27亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 200,996,487.21 | 812,349,118.11 | 597,031,023.17 | 416,670,322.17 |
| 营业收入 | 200,996,487.21 | 812,349,118.11 | 597,031,023.17 | 416,670,322.17 |
| 二、营业总成本 | 155,775,268.01 | 638,046,793.58 | 459,087,621.87 | 302,365,752.25 |
| 营业成本 | 60,388,379.17 | 245,335,524.13 | 173,384,209.12 | 125,899,235.73 |
| 税金及附加 | 3,925,614 | 16,059,493.93 | 12,011,074.5 | 8,070,593.4 |
| 销售费用 | 44,790,436.58 | 195,733,232.04 | 150,731,663.36 | 91,044,742.2 |
| 管理费用 | 33,649,803.51 | 132,470,636.52 | 87,376,552.45 | 54,911,117.02 |
| 研发费用 | 12,818,416.63 | 44,438,240.4 | 31,911,748.38 | 19,634,385.2 |
| 财务费用 | 202,618.12 | 4,009,666.56 | 3,672,374.06 | 2,805,678.7 |
| 其中:利息费用 | 212,330.06 | 3,831,389.8 | 3,495,325.71 | 2,629,797.03 |
| 其中:利息收入 | 40,809.99 | 233,974.56 | 174,477.11 | 102,547.13 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 3,771,221.64 | 33,093,574.46 | 28,104,091.41 | 20,035,272.46 |
| 资产处置收益 | 1,263,594.29 | 21,064,523.22 | 111,916.62 | 111,916.62 |
| 资产减值损失(新) | -643,112.72 | -11,737,649.89 | -6,148,331.99 | -6,910,539.37 |
| 信用减值损失(新) | -941,285.35 | 644,123.5 | -139,807.22 | -365,014.1 |
| 其他收益 | 1,631,251.98 | 7,234,572.61 | 4,546,450.21 | 2,768,166.43 |
| 四、营业利润 | 50,302,889.04 | 224,601,468.43 | 164,417,720.33 | 129,944,371.96 |
| 加:营业外收入 | 23,469.32 | 252,298.78 | 174,625.65 | 116,703.53 |
| 减:营业外支出 | 64,402.11 | 1,011,610.04 | 719,776.26 | 609,521.92 |
| 五、利润总额 | 50,261,956.25 | 223,842,157.17 | 163,872,569.72 | 129,451,553.57 |
| 减:所得税费用 | 5,638,185.43 | 26,376,950.11 | 19,265,997.25 | 15,514,593.83 |
| 六、净利润 | 44,623,770.82 | 197,465,207.06 | 144,606,572.47 | 113,936,959.74 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 44,623,770.82 | 197,465,207.06 | 144,606,572.47 | 113,936,959.74 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 44,289,745.45 | 195,116,716.86 | 142,723,526.51 | 112,423,618.95 |
| 少数股东损益 | 334,025.37 | 2,348,490.2 | 1,883,045.96 | 1,513,340.79 |
| 扣除非经常损益后的净利润 | 42,463,983.12 | 173,880,085.66 | 140,386,721.11 | 111,149,021.06 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.14 | 0.61 | 0.45 | 0.35 |
| (二)稀释每股收益 | 0.14 | 0.61 | 0.45 | 0.35 |
| 九、综合收益总额 | 44,623,770.82 | 197,465,207.06 | 144,606,572.47 | 113,936,959.74 |
| 归属于母公司股东的综合收益总额 | 44,289,745.45 | 195,116,716.86 | 142,723,526.51 | 112,423,618.95 |
| 归属于少数股东的综合收益总额 | 334,025.37 | 2,348,490.2 | 1,883,045.96 | 1,513,340.79 |
| 公告日期 | 2026-04-24 | 2026-04-24 | 2025-10-28 | 2025-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |